237 related articles for article (PubMed ID: 28328217)
21. GnRH Stimulates Peptidylarginine Deiminase Catalyzed Histone Citrullination in Gonadotrope Cells.
Khan SA; Edwards BS; Muth A; Thompson PR; Cherrington BD; Navratil AM
Mol Endocrinol; 2016 Oct; 30(10):1081-1091. PubMed ID: 27603413
[TBL] [Abstract][Full Text] [Related]
22. D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy.
Bicker KL; Anguish L; Chumanevich AA; Cameron MD; Cui X; Witalison E; Subramanian V; Zhang X; Chumanevich AP; Hofseth LJ; Coonrod SA; Thompson PR
ACS Med Chem Lett; 2012 Oct; 3(12):1081-1085. PubMed ID: 23420624
[TBL] [Abstract][Full Text] [Related]
23. The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs).
Nemmara VV; Subramanian V; Muth A; Mondal S; Salinger AJ; Maurais AJ; Tilvawala R; Weerapana E; Thompson PR
ACS Chem Biol; 2018 Mar; 13(3):712-722. PubMed ID: 29341591
[TBL] [Abstract][Full Text] [Related]
24. Development and use of clickable activity based protein profiling agents for protein arginine deiminase 4.
Slack JL; Causey CP; Luo Y; Thompson PR
ACS Chem Biol; 2011 May; 6(5):466-76. PubMed ID: 21265574
[TBL] [Abstract][Full Text] [Related]
25. PAD2 Activity Monitored via a Fluorescent Substrate Analog.
Sabulski MJ; Wang Y; Pires MM
Chem Biol Drug Des; 2015 Oct; 86(4):599-605. PubMed ID: 25643806
[TBL] [Abstract][Full Text] [Related]
26. Profiling Protein Arginine Deiminase 4 (PAD4): a novel screen to identify PAD4 inhibitors.
Knuckley B; Luo Y; Thompson PR
Bioorg Med Chem; 2008 Jan; 16(2):739-45. PubMed ID: 17964793
[TBL] [Abstract][Full Text] [Related]
27. Reactive oxygen species inhibit catalytic activity of peptidylarginine deiminase.
Damgaard D; Bjørn ME; Jensen PØ; Nielsen CH
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1203-1208. PubMed ID: 28933232
[TBL] [Abstract][Full Text] [Related]
28. Molecular targeting of protein arginine deiminases to suppress colitis and prevent colon cancer.
Witalison EE; Cui X; Causey CP; Thompson PR; Hofseth LJ
Oncotarget; 2015 Nov; 6(34):36053-62. PubMed ID: 26440311
[TBL] [Abstract][Full Text] [Related]
29. Calcium Regulates the Nuclear Localization of Protein Arginine Deiminase 2.
Zheng L; Nagar M; Maurais AJ; Slade DJ; Parelkar SS; Coonrod SA; Weerapana E; Thompson PR
Biochemistry; 2019 Jul; 58(27):3042-3056. PubMed ID: 31243954
[TBL] [Abstract][Full Text] [Related]
30. Noncovalent Protein Arginine Deiminase (PAD) Inhibitors Are Efficacious in Animal Models of Multiple Sclerosis.
Tejeda EJC; Bello AM; Wasilewski E; Koebel A; Dunn S; Kotra LP
J Med Chem; 2017 Nov; 60(21):8876-8887. PubMed ID: 29045782
[TBL] [Abstract][Full Text] [Related]
31. Novel furan-containing peptide-based inhibitors of protein arginine deiminase type IV (PAD4).
Teo CY; Tejo BA; Leow ATC; Salleh AB; Abdul Rahman MB
Chem Biol Drug Des; 2017 Dec; 90(6):1134-1146. PubMed ID: 28581157
[TBL] [Abstract][Full Text] [Related]
32. Mechanical stretching elevates peptidyl arginine deiminase 2 expression in astrocytes.
Algeciras ME; Takahara H; Bhattacharya SK
Curr Eye Res; 2008 Nov; 33(11):994-1001. PubMed ID: 19085382
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and molecular docking study of some 5,6-dichloro-2-cyclopropyl-1H-benzimidazole derivatives bearing triazole, oxadiazole, and imine functionalities as potent inhibitors of urease.
Menteşe E; Bektaş H; Sokmen BB; Emirik M; Çakır D; Kahveci B
Bioorg Med Chem Lett; 2017 Jul; 27(13):3014-3018. PubMed ID: 28526368
[TBL] [Abstract][Full Text] [Related]
34. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target.
McElwee JL; Mohanan S; Griffith OL; Breuer HC; Anguish LJ; Cherrington BD; Palmer AM; Howe LR; Subramanian V; Causey CP; Thompson PR; Gray JW; Coonrod SA
BMC Cancer; 2012 Oct; 12():500. PubMed ID: 23110523
[TBL] [Abstract][Full Text] [Related]
35. Potential role for PAD2 in gene regulation in breast cancer cells.
Cherrington BD; Zhang X; McElwee JL; Morency E; Anguish LJ; Coonrod SA
PLoS One; 2012; 7(7):e41242. PubMed ID: 22911765
[TBL] [Abstract][Full Text] [Related]
36. Role of peptidylarginine deiminase 2 (PAD2) in mammary carcinoma cell migration.
Horibata S; Rogers KE; Sadegh D; Anguish LJ; McElwee JL; Shah P; Thompson PR; Coonrod SA
BMC Cancer; 2017 May; 17(1):378. PubMed ID: 28549415
[TBL] [Abstract][Full Text] [Related]
37. Haloacetamidine-based inactivators of protein arginine deiminase 4 (PAD4): evidence that general acid catalysis promotes efficient inactivation.
Knuckley B; Causey CP; Pellechia PJ; Cook PF; Thompson PR
Chembiochem; 2010 Jan; 11(2):161-5. PubMed ID: 20014086
[TBL] [Abstract][Full Text] [Related]
38. Identification of multiple structurally distinct, nonpeptidic small molecule inhibitors of protein arginine deiminase 3 using a substrate-based fragment method.
Jamali H; Khan HA; Stringer JR; Chowdhury S; Ellman JA
J Am Chem Soc; 2015 Mar; 137(10):3616-21. PubMed ID: 25742366
[TBL] [Abstract][Full Text] [Related]
39. Modulation of peptidyl arginine deiminase 2 and implication for neurodegeneration.
Bhattacharya SK; Bhat MB; Takahara H
Curr Eye Res; 2006 Dec; 31(12):1063-71. PubMed ID: 17169845
[TBL] [Abstract][Full Text] [Related]
40. Structures of human peptidylarginine deiminase type III provide insights into substrate recognition and inhibitor design.
Funabashi K; Sawata M; Nagai A; Akimoto M; Mashimo R; Takahara H; Kizawa K; Thompson PR; Ite K; Kitanishi K; Unno M
Arch Biochem Biophys; 2021 Sep; 708():108911. PubMed ID: 33971157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]